Improve dosimetric outcome in stage III non-small-cell lung cancer treatment using spot-scanning proton arc (SPArc) therapy
Abstract Background To evaluate spot-scanning proton arc therapy (SPArc) and multi-field robust optimized intensity modulated proton therapy (RO-IMPT) in treating stage III non-small-cell lung cancer (NSCLC) patients. Methods Two groups of stage IIIA or IIIB NSCLC patients (group 1: eight patients w...
Main Authors: | Xiaoqiang Li, Peyman Kabolizadeh, Di Yan, An Qin, Jun Zhou, Ye Hong, Thomas Guerrero, Inga Grills, Craig Stevens, Xuanfeng Ding |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-02-01
|
Series: | Radiation Oncology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13014-018-0981-6 |
Similar Items
-
Improve the dosimetric outcome in bilateral head and neck cancer (HNC) treatment using spot-scanning proton arc (SPArc) therapy: a feasibility study
by: Gang Liu, et al.
Published: (2020-01-01) -
Feasibility study: spot-scanning proton arc therapy (SPArc) for left-sided whole breast radiotherapy
by: Sheng Chang, et al.
Published: (2020-10-01) -
Lung Stereotactic Body Radiotherapy (SBRT) Using Spot-Scanning Proton Arc (SPArc) Therapy: A Feasibility Study
by: Gang Liu, et al.
Published: (2021-04-01) -
Linear Energy Transfer Incorporated Spot-Scanning Proton Arc Therapy Optimization: A Feasibility Study
by: Xiaoqiang Li, et al.
Published: (2021-07-01) -
Spot Scanning Proton Therapy for Sinonasal Malignant Tumors
by: Koichiro Nakajima, MD, et al.
Published: (2021-06-01)